A Single Immunization With Modified Vaccinia Virus Ankara-Based Influenza Virus H7 Vaccine Affords Protection in the Influenza A(H7N9) Pneumonia Ferret Model

Joost Kreijtz, Lidewij Wiersma, Heidi Gruyter, Stella Trierum, Geert Amerongen, Koert Stittelaar, Ron Fouchier, Ab Osterhaus, G Sutter, Guus Rimmelzwaan

Research output: Contribution to journalArticleAcademicpeer-review

28 Citations (Scopus)


Since the first reports in early 2013, >440 human cases of infection with avian influenza A(H7N9) have been reported including 122 fatalities. After the isolation of the first A(H7N9) viruses, the nucleotide sequences became publically available. Based on the coding sequence of the influenza virus A/Shanghai/2/2013 hemagglutinin gene, a codon-optimized gene was synthesized and cloned into a recombinant modified vaccinia virus Ankara (MVA). This MVA-H7-Sh2 viral vector was used to immunize ferrets and proved to be immunogenic, even after a single immunization. Subsequently, ferrets were challenged with influenza virus A/Anhui/1/2013 via the intratracheal route. Unprotected animals that were mock vaccinated or received empty vector developed interstitial pneumonia characterized by a marked alveolitis, accompanied by loss of appetite, weight loss, and heavy breathing. In contrast, animals vaccinated with MVA-H7-Sh2 were protected from severe disease.
Original languageUndefined/Unknown
Pages (from-to)791-800
Number of pages10
JournalJournal of Infectious Diseases
Issue number5
Publication statusPublished - 2015

Research programs

  • EMC MM-04-27-01

Cite this